Keyphrases
Chronic Obstructive Pulmonary Disease
100%
Inhaled Corticosteroids
75%
Escherichia Coli
51%
Bacteremia
51%
Denmark
50%
Confidence Interval
43%
Retrospective Cohort Study
43%
Antibiotic Use
42%
Streptococcal Species
37%
Bloodstream Infection
37%
Antibiotic Stewardship Program
37%
Pivmecillinam
34%
Antibiotics
29%
Hazard Ratio
25%
Catheter-associated Urinary Tract Infection (CAUTI)
25%
Stenotrophomonas Maltophilia
25%
Penicillin Allergy
25%
Pseudomonas Aeruginosa (P. aeruginosa)
25%
Infective Endocarditis
25%
Delabeling
25%
All-cause Mortality
23%
Inhaled Corticosteroid Therapy
22%
Capital Region
21%
Cephalosporins
20%
Corticosteroid Dose
19%
Dose Effect
18%
Odds Ratio
18%
Low Risk
16%
Observational Cohort Study
15%
Risk of Death
15%
Multi-regional
15%
Treatment Failure
15%
Hospital Intervention
15%
Urinary Tract Infection
14%
Haemophilus Influenzae
14%
Epidemiological Study
14%
Multidrug-resistant Organisms
14%
Oral Antibiotics
13%
Herlev
13%
Streptococcus Pneumoniae
13%
Existing Data
12%
Antimicrobial
12%
Lower Respiratory Tract Infection
12%
Haemophilus Influenzae Infections
12%
Short Course
12%
Non-healthcare Workers
12%
Pulmonary Risk
12%
Antibiotic Restriction
12%
Community-acquired Infections
12%
Controlled Interrupted Time Series
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
97%
Antibiotics
81%
Chronic Obstructive Lung Disease
75%
Bacteremia
52%
Pivmecillinam
37%
Infection
37%
Antibiotic Agent
35%
Escherichia coli
32%
Urinary Tract Infection
25%
Penicillin Allergy
25%
Haemophilus influenzae
25%
All Cause Mortality
20%
Amoxicillin
15%
Epidemiology
14%
Extended Spectrum Beta Lactamase
14%
Quinolone Derivative
13%
Lower Respiratory Tract Infection
12%
Antiinfective Agent
12%
Sepsis
12%
Moraxella catarrhalis
12%
Gentamicin
12%
Community Acquired Infection
12%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
12%
Mycosis
12%
Bacterial Endocarditis
12%
Prevalence
12%
Pneumococcal Infection
12%
Stenotrophomonas maltophilia
12%
Bloodstream Infection
12%
Pseudomonas aeruginosa
12%
Fungemia
12%
Antibiotic Prophylaxis
12%
Clavulanic Acid
12%
SARS Coronavirus
12%
Mixed Infection
12%
Ciprofloxacin
11%
Cephalosporin Derivative
9%
Respiratory Tract
8%
Penicillin Derivative
7%
Delayed Hypersensitivity
7%
Anaphylaxis
7%
Acute Kidney Failure
6%
Septic Shock
6%
Prospective Study
5%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
62%
Outpatient
40%
Infection
39%
Antibiotics
28%
Bacteremia
26%
Bloodstream Infection
25%
Stenotrophomonas maltophilia
25%
Cohort Analysis
25%
Hazard Ratio
16%
Retrospective Cohort Study
15%
All Cause Mortality
15%
Escherichia coli
14%
Antibiotic Therapy
13%
Lower Respiratory Tract
13%
Proportional Hazards Model
12%
Targeted Therapy
12%
Lower Respiratory Tract Infection
12%
Community Acquired Infection
12%
Emergency Department
12%
Echocardiography
12%
Lactam
12%
Mecillinam
12%
Infective Endocarditis
12%
Haemophilus influenzae
12%
Moraxella catarrhalis
12%
Patient Referral
12%
Drug Megadose
12%
Klebsiella
12%
Methicillin Resistant Staphylococcus Aureus
12%
Prognostic Factor
12%
Pneumococcal Infection
12%
Cohort Effect
12%
Urinary Tract
12%
Sepsis
12%
Prostate Biopsy
12%
Antibiotic Prophylaxis
12%
Biopsy
12%
Transrectal Ultrasonography
12%
Intensive Care Unit
12%
Influenza A
12%
Omicron Coronavirus Variant
12%
Influenza B
12%
Pneumococcus
10%
Odds Ratio
10%
Pivmecillinam
9%
Amoxicillin/Clavulanic Acid
9%
Blood Culture
7%
Low Drug Dose
7%
Septic Shock
6%
Transesophageal Echocardiography
5%